Brief: Nyxoah Completes Milestone in Development oF DREAM U.S Pivotal Study
March 6 (Reuters) - Nyxoah SA NYXH.BR :
* REG-NYXOAH ANNOUNCES ACHIEVEMENT OF KEY CLINICAL AND
REGULATORY
MILESTONES
* HAS COMPLETED ALL 115 IMPLANTS IN ITS DREAM U.S. PIVOTAL
STUDY,
SUBMITTED FIRST MODULE IN MODULAR PMA SUBMISSION AND IMPLANTED
FIRST PATIENT IN ACCCESS U.S. PIVOTAL STUDY
Source text for Eikon: ID:nGNE88rNgL
Further company coverage: NYXH.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nyxoah SA
See all newsBelgium's Nyxoah Q3 revenue rises on US commercialization
Brief: Nyxoah SA Q3 Gross Profit EUR 5.785 Million
Brief: Nyxoah SA Submits Pma Supplement To FDA To Expand Genio Indication To Complete Concentric Collapse Patients
Brief: Nyxoah Says Co Appoints Liam Kelly As Chief Executive Officer Effective October 1
Brief: Cvrx Appoints John Landry As Chief Financial Officer